Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/1991
06/23/1991WO1991009945A1 Neutrophil chemoattractants
06/23/1991CA2072012A1 Neutrophil chemoattractants
06/19/1991EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications
06/19/1991CN1052310A Hiv related peptides
06/18/1991CA1285099C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
06/13/1991WO1991008482A1 Antibody variable domain conjugates
06/13/1991WO1991008478A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
06/13/1991WO1991008225A1 Hexapeptides with sulphate ester groups
06/12/1991EP0432029A1 Process for the preparation of synergistins
06/12/1991EP0431784A2 Methods for treating retroviral infection
06/12/1991EP0431350A1 New polypeptide compound and a process for preparation thereof
06/12/1991EP0431327A1 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
06/12/1991EP0431113A1 Atrial peptide derivatives
06/11/1991US5023237 Methods and compositions for healing ulcers
06/11/1991US5023233 Fibrinogen receptor antagonists
06/08/1991WO1991009125A1 Proteins and nucleic acids
06/08/1991WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins
06/08/1991WO1991009053A1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
06/08/1991CA2069449A1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
06/08/1991CA2069105A1 Proteins and nucleic acids
06/08/1991CA2031644A1 Peptide antiviral agents
06/06/1991WO1991007978A1 Synthetic calcitonin peptides
06/06/1991CA2069943A1 Synthetic calcitonin peptides
06/05/1991EP0430538A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1
06/05/1991EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component
06/05/1991EP0429788A2 Fragments of porcine somatotropin and antibodies thereto enhancing porcine somatotropin activity
06/05/1991EP0429537A1 Atrial natriuretic peptide clearance inhibitors
06/05/1991CN1051914A Peptides
06/04/1991US5021567 8-hydroxyquinoline chelating agents
06/04/1991US5021403 Antibiotic agents
06/04/1991US5021341 Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
06/02/1991WO1991007977A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991CA2069902A1 Peptides and antibodies that inhibit integrin-ligand binding
05/1991
05/31/1991CA2030293A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1
05/30/1991WO1991007496A1 Cloning and expression of genes encoding for polypeptides comprised of one or more repeating amino acid sequences
05/30/1991WO1991007483A2 Mammalian pancreatic cholesterol esterase
05/30/1991WO1991007430A1 Peptides containing cyclic tripeptides
05/30/1991WO1991007429A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety
05/30/1991WO1991007189A1 Conglutinin fragments, their production and use
05/29/1991EP0429242A2 Specific binding agents
05/29/1991EP0428849A2 Retroviral protease inhibitors
05/29/1991CN1051757A Polypeptide compound and process for preparation thereof
05/28/1991US5019646 Polypeptides with fibronectin activity
05/28/1991US5019386 Hepatitis B vaccine
05/28/1991CA2030720A1 Hexapeptides with sulphate ester groups
05/23/1991WO1991007980A1 Compositions for treating ischemia-related neuronal damage
05/23/1991CA2030212A1 Peptides
05/22/1991EP0428486A1 Polymyxin conjugates
05/22/1991EP0428367A1 Isolation and structural elucidation of the cytostatic linear depsipetide dolastatin 14
05/22/1991EP0428000A1 Fluorogenic substrates for the detection of proteolytic enzyme activity
05/22/1991EP0427768A1 Polypeptide pertussis toxin vaccine
05/22/1991CN1051600A Dye transfer inhibition
05/21/1991US5017689 Analgesics
05/21/1991CA2030254A1 Methods of treating retroviral infection
05/18/1991WO1991007500A1 Specific binding agents
05/18/1991WO1991007490A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2135744A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2068728A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2066670A1 Specific binding agents
05/16/1991WO1991006566A1 Novel compounds
05/16/1991CA2029997A1 Polymyxin conjugates
05/15/1991EP0427458A2 Use of heptapeptides in the treatment or prophylaxis of muscle wasting
05/15/1991EP0426838A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
05/14/1991WO1991007434A1 Control of milk secretion
05/14/1991WO1991007431A1 Metal-peptide compositions and methods for stimulating hair growth
05/14/1991US5015628 Oral diseases, fractionating a digest of casein, alpha-s-casein, beta-casein or salt
05/14/1991CA2068515A1 Control of milk secretion
05/14/1991CA2029766A1 Polypeptide compound and a process for preparation thereof
05/09/1991WO1991007433A1 Peptide and process for preparing cyclic peptide
05/09/1991CA2045495A1 Peptides and processes for producing cyclic peptides
05/08/1991EP0426314A2 HIV related peptides
05/08/1991CN1051200A Improved process for production of a-21978c derivatives
05/07/1991WO1991006563A1 Reduced irreversible bombesin antagonists
05/07/1991US5013721 Anorexigenic and hypotensive peptides
05/07/1991CA2045494A1 Reduced irreversible bombesin antagonists
05/04/1991CA2029268A1 Peptides aiding nerve regeneration
05/04/1991CA2029123A1 Fluorogenic substrates for the detection of proteolytic enzyme activity
05/02/1991WO1991005858A1 A microperoxidase preparation containing a hemopeptide as an active component
05/02/1991WO1991005567A1 Vaccins for protecting against infections by hiv virus, process for producing the same and their use as diagnostic and immunotherapy means
05/02/1991EP0425212A2 Cyclic anti-aggregatory peptides
05/02/1991EP0425082A1 Bordetella vaccines
05/02/1991EP0424670A1 ZNS-active hexapeptides with antiamnestic activity
05/02/1991EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
05/02/1991CA2029018A1 Analogues of gonadotropin releasing hormone
05/01/1991WO1991006543A1 GnRH ANALOGS
05/01/1991WO1991006356A1 Method to identify analyte-binding ligands
05/01/1991WO1991006318A1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna
05/01/1991CA2072637A1 Method to identify analyte-binding ligands
05/01/1991CA2066184A1 Gnrh analogs
05/01/1991CA2027317A1 Vaccine composition with non-immunosuppressive t-cell epitope component
04/1991
04/30/1991US5011912 Calcium-dependent affinity for selected peptide terminal sequence
04/30/1991US5011909 Novel compositions and process for inhibiting digestion in blood-sucking insects
04/30/1991US5011825 Treatment of hypertension, diabetes, edema
04/30/1991CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
04/28/1991CA2028517A1 Enhancement of porcine somatotropin activity
04/24/1991WO1991005799A1 Polypeptide inhibitors of gamma interferon
04/24/1991EP0423649A1 Peptides and use thereof
04/24/1991EP0423358A1 Postostatin and related compound thereof, or their salts
04/24/1991EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
04/24/1991EP0423315A1 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
1 ... 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 ... 423